Novo Nordisk insulin finally approved in the US

Danish pharmaceutical giant has high hopes for products

The Danish pharmaceutical giant Novo Nordisk has announced that the US health authority, the FDA, has approved two of its products for the treatment of diabetes on the American market.

It has taken two years for the FDA to approve the two products, Tresiba and Ryzodeg, which help treat adults suffering from Type-1 and Type-2 diabetes.

“Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes, and we are proud to bring forward the first new basal insulin molecule to be approved by the FDA in 10 years,” said Jesper Høiland, the president of Novo Nordisk in the US.

“Novo Nordisk is excited to launch Tresiba in the United States in the first quarter of 2016.”

READ MORE: Novo Nordisk to invest billions into US factory

Huge health issue
Novo Nordisk originally applied for approval on the US market in 2013, but the FDA was not convinced by the product, so the company undertook a clinical study regarding the risk of using the product.

The company has massive expectations for the US market and expects the products, already approved in Europe and Japan, to be among the leading diabetic products there within a few short years.

Over 29 million people are affected by diabetes in the US. Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases. The number of Americans with diabetes has tripled over the past 30 years.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.